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Abstract
Background: Colic could be accompanied by changes in the morphology and physiology of organs
and tissues, such as the intestine. This process might be, at least in part, due to the accumulation
of oxidative damage induced by reactive oxygen (ROS) and reactive nitrogen species (RNS),
secondary to intestinal ischemia. Glutathione (GSH), being the major intracellular thiol, provides
protection against oxidative injury. The aim of this study was to investigate whether ischemia-
induced intestinal injury could be related with alterations in GSH metabolism.
Results: Ischemia induced a significant increase in lipid hydroperoxides, nitric oxide and carbon
monoxide, and a reduction in reduced glutathione, and adenosine triphosphate (ATP) content, as
well as in methionine-adenosyl-transferase and methyl-transferase activities.
Conclusion: Our results suggest that ischemia induces harmful effects on equine small intestine,
probably due to an increase in oxidative damage and proinflammatory molecules. This effect could
be mediated, at least in part, by impairment in glutathione metabolism.
Background
Colic refers to any cause of abdominal pain and is the
leading cause of death in horses. Much of the mortality is
associated with ischemic-injured intestine because of the
rapid deterioration of the intestinal barrier, absorption of
bacterial lipopolysacharide and subsequent circulatory
collapse [1]. Certain processes that can take place during
equine colic, like intestinal ischemia and/or endotoxemia
[1-4] can subject the intestine to an increased burden of
oxidative stress [4,5], with the subsequent accumulation
of reactive oxygen species (ROS) and reactive nitrogen
species (RNS). ROS are highly reactive molecules which
are mainly generated in mitochondria during oxygen
metabolism. Impairment in mitochondrial function may
reduce the energy supply to the cells. It has been suggested
that the increase in oxidative stress could be, at least in
part, responsible for this fact [6].
Two molecules that have been recently involved in oxida-
tive damage and inflammatory response are Nitric oxide
(NO) and Carbon monoxide (CO). Nitric oxide can act as
both inflammatory mediator and RNS, either directly or
through peroxynitrites generated by its interaction with
O2
- [7,8]. CO is one of the elements of the heme-oxygen-
Published: 18 March 2009
BMC Veterinary Research 2009, 5:10 doi:10.1186/1746-6148-5-10
Received: 22 February 2008
Accepted: 18 March 2009
This article is available from: http://www.biomedcentral.com/1746-6148/5/10
© 2009 Marañón et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Veterinary Research 2009, 5:10 http://www.biomedcentral.com/1746-6148/5/10
Page 2 of 9
(page number not for citation purposes)
ase 1 (HO-1)-CO pathway, which has been proposed to
constitute a defence system against oxidative and inflam-
matory damage [9].
In the past, many studies have been shown that glutath-
ione (GSH), a well-known antioxidant [10,11] protects
cells and organs from various forms of injury induced by
hypoxia, ischemia, cold preservation and drugs [12,13].
This has been used as evidence for a role of oxygen free
radicals in such injury because the metabolism of GSH
suppresses the cytotoxic effects of the reactive radicals
[14,15]. Nevertheless, GSH is also essential in preserving
the ability of the cell to generate ATP and to maintain
membrane integrity [13], and it has been suggested that
GSH may protect cells by mechanisms independent of its
antioxidant properties.
Oxidative stress secondary to free radical generation may
play a role in the tissue damage associated with intestinal
ischemia [5]. Mitochondria are major producers of ROS,
i.e. O2
- and H2O2. H2O2if not reduced to water, can lead
to the formation of very reactive hydroxyl radicals result-
ing in the formation of lipid hydroperoxides (LPO) that
can damage mitochondria membranes and functions
reducing the energy supply to the cells. Since mitochon-
dria do not contain catalase, GSH as a cofactor of the glu-
tathione peroxidase is the only mitochondrial defence to
coupe with H2O2 produced endogenously in aerobic cells.
Thus, GSH is critical in protecting unsaturated fatty acids
in membrane phospholipids from peroxidation by attack
of oxygen free radicals. GSH depletion results in cell injury
and death in several cell types and organs [15,16] and it
has been shown that glutathione is required for intestinal
function [16], but, to our knowledge, no studies concern-
ing the role of glutathione metabolism in horse intestine
have been done.
On the other hand, S-Adenosyl methionine (SAMe) an
endogenous metabolite synthesized in the cytosol of all
types of cells from ATP and methionine [17], in a reaction
catalyzed by the enzyme methionine-adenosyl-transferase
(MAT), plays a critical role in the synthesis of glutathione
[18,19]. SAMe plays a critical role in the synthesis of glu-
tathione (GSH) [18,19]. Conversely, depletion of GSH
could result in a decrease of MAT activity, which in turn
can result in a further decrease of GSH levels thus increas-
ing cell damage. SAMe also participates in polyamine syn-
thesis and it acts as methyl donor for most biological
transmethylation reactions, catalysed by methyl-trans-
ferases (MetTase), including the methylation of phos-
phatidyl ethanolamine to produce phosphatidyl choline
(PC), which is an essential molecule for cell membrane
integrity.
The aim of this study was to asses a possible association
between alterations in the glutathione metabolism and
intestinal ischemia-induced oxidative/antioxidative
imbalance in horses. For this purpose GSH, LPO and ATP
content, as well as NO and CO release was determined in
intestinal tissue of horses. Additionally, MAT and Met
Tase activities have also been investigated.
Methods
Patients
Twenty-nine adult horses with acute abdominal pain sub-
jected to emergency abdominal surgery of the small intes-
tine, referred to our clinic during the last year, were used.
The ages ranged from 5 to 20 years with a mean of 11
years. On arrival, the same protocol for acute abdominal
emergency reception was applied to each horse. A com-
plete anamnesis was performed at time of presentation
(duration of signs, previous medical treatment....), and a
clinical evaluation to asses degree of pain, response to
analgesia, abdominal distention, hydration status, rectal
examination findings and amount of gastric reflux.
Degree of abdominal pain was assessed by the attending
clinicians as mild (occasional pawing, occasionally turn-
ing the head to the flank, stretching out), moderate
(cramping with attempts to lie down, kicking at the abdo-
men, laying down and attempting to roll or rolling) or
severe (sweating, dropping to the ground, violent rolling)
[20].
At presentation, rectal temperature varied from 37.6 to
38.5°C (38.1 ± 0.7°C), heart rate ranged from 45 to 90
beats/min (68 ± 23 beats/min), and respiratory rate
ranged from 10 to 30 breaths/min (20 ± 10 breaths/min).
All of the 29 colic horses had moderate or severe pain. The
response to analgesia was mild in 14 horses and poor in
15. Transrectal palpation of the abdominal organs was
performed in all cases.
The cases were composed of one inguinal hernia, 5 lipo-
mas, 2 intussusceptions (parasites), 1 horse with small
intestinal adhesions and 20 intestinal volvulus. All horses
received the same standard protocol of medication (flu-
nixin-meglumine+xylazine).
Horses were premedicated with intravenous (IV) romifi-
dine and anaesthesia was induced with guaifenesin+thio-
pental and was maintained with isoflurane as required.
Lactated Ringer's solution (LRS) was given to all horses
during anaesthesia. The outer parts of the resected intes-
tine were harvested, divided in two portions: proximal
and distal (a 20 cm segment that we assumed to be viable)
to the stenosis, frozen in liquid nitrogen and stored frozen
at -80°C.
Four adult horses destined for euthanasia for reasons
unrelated to the cardio-vascular system or gastrointestinal
tract were used as reference control.BMC Veterinary Research 2009, 5:10 http://www.biomedcentral.com/1746-6148/5/10
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All the studies were approved by the Complutense Univer-
sity Ethical Committee and adhered to the guidelines of
Commission Directive 86/609/EEC (The Council Direc-
tive of the European Community) concerning the protec-
tion of animals used for experimental and other scientific
purposes. The National legislation, in agreement with this
Directive, is defined in Royal Decree n° 1202/2005.
Isolation of tissue mitochondria
The tissue samples were placed in an ice-cold homogeni-
zation buffer (0.32 M sucrose, 1 mM K+EDTA, and 10 mM
Tris-Cl, pH 7.4), containing 2.5 mg/ml of fatty acid-free
bovine serum albumin (BSA) and 0.3 mM phenylmethyl-
sulfonyl fluoride (PMSF, a protease inhibitor). The sec-
tions were minced and homogenized with 2 ml of
homogenization buffer per gram of tissue, using a Teflon-
glass homogenizer. The homogenate was centrifuged at
500 × g at 4°C for 5 min. The pellet was washed with the
homogenization buffer and centrifuged at 500 × g for 5
min (4°C). The supernatant was centrifuged at 10,000 × g
at 4°C for 15 min. The mitochondrial pellet was washed
once and then resuspended in homogenization buffer.
After centrifugation the supernatant was used for cyto-
chrome c  determination. The mitochondrial pellet was
incubated with lyses buffer and used for NO and CO
determination.
Biochemical determinations
For GSH assessment, a specific colorimetric method was
used [21]. Briefly, glutathione was sequentially oxidized
by 5-5' dithio-bis (2-dinitrobenzoic acid) (DTNB) and
reduced by NADPH in the presence of glutathione
disulfide reductase, which results in the formation of 5-
thio-2-nitrobenzoic acid (TNB). The rate of TNB forma-
tion is measured spectrophotometrically at 412 nm.
Cellular content of adenosine tri phosphate (ATP) and
lipid hydroperoxides (LPO) were measured by spectro-
photmetry using commercially available kits (Sigma, St.
Louis, Missouri, USA; Camille Biochemical Company,
Thousand Oaks, CA, USA, and).
For ATP determination, a portion of tissue was homoge-
nised in tris-EDTA buffer, pH 7.75, containing 0.3%
trichloroacetic acid, and centrifuged (3000 g, for 10 min-
utes). ATP measurement was based on two consecutive
reactions; in the first one, ATP is transformed to adenosyl
diphosphate (ADP) and 1,3-diphosphoglycerate in the
presence of 3-phosphoglycerate phosphokinase); in the
following reaction, catalyzed by glyceraldehyde-phos-
phate-dehydrogenase, 1,3-diphosphoglycerate in the
presence of NADH+H is transformed in glyceraldehyde-3-
P and NAD+P. The reduction of absorbance at 340 nm
due to the oxidation of NADH to NAD is proportional to
the amount of ATP in the sample [22,23].
Lipid hydroperoxides were extracted from the sample into
chloroform before performing the assay. Briefly, tissue
was homogenized in buffer phosphate saturated metha-
nol and centrifuged, 3,000 × g, for 10 minutes. Five hun-
dred microliters of the supernatant were aliquot into a
glass test tube and an equal volume of cold chloroform
was added and mixed thoroughly by vortexing, and cen-
trifuged again at 1,500 × g for 5 minutes at 0°C. Bottom
chloroform layer was collected and transferred to another
test tube for LPO measurement. The basis of the LPO
determination is the reaction of hydroperoxides with 10-
N-methylcarbamoil-3,7-dimethylamino-10-10-fenotia-
cine, catalyzed by haemoglobin, which leads to methyl-
ene blue formation. The methylene blue formed was then
measured colorimetrically [22,23].
NO release was measured by the Griess reaction as NO2
concentration after NO3 reduction to NO2. Briefly, sam-
ples were deproteinized by the addition of sulfosalicylic
acid, were then incubated for 30 min at 4°C, and subse-
quently centrifuged for 20 minutes at 12,000 g. After incu-
bation of the supernatants with Escherichia coli NO3
reductase (37°, 30 min), 1 ml of Griess reagent (0.5%
naphthylenediamine dihydrochloride, 5% sulfonilamide,
25% H3PO4) was added. The reaction was performed at
22°C for 20 min, and the absorbance at 546 nm was
measured, using NaNO2 solution as standard. The meas-
ured signal is linear from 1 to 150 μM (r = 0.994, P <
0.001, n = 5), and the detection threshold is ~2 μM.
To quantify the amount of CO released, the ratio of car-
boxy-haemoglobin after haemoglobin addition was
measured. Haemoglobin (4 μM) was added to samples
and the mixture was allowed to react for 1 min, to be sure
of a maximum binding of CO to haemoglobin. Then,
samples were diluted with a solution containing phos-
phate buffer (0.01 mol/L monobasic potassium phos-
phate/dibasic potassium phosphate, pH 6.85) containing
sodium dithionite, and after 10 min at room temperature,
absorbance was measured at 420 and 432 nm against a
matched curve containing only buffer.
MAT activity was assayed as described by Cantoni [24,25])
and Duce [25]. Briefly, the incubation mixture consisted
of 100 mM Tris-HCl (pH 7.8), 200 mM KCl, 10 mM
MgCl2, 1 mM dithiothreitol,, 5 mM ATP and 5 mM L-
methionine containing 0.2 μCi/ml methyl-L-[3H]methio-
nine (Radiochemical Center, Amersham, Buckingham-
shire, UK). The reaction was initiated by the addition of
the sample and 30 min later was stopped with cold dis-
tilled water. The incubation mixture was immediately
applied to a 2 ml Dowex AG 50 W column. The column
was washed with 20 ml distilled water and the [3H]SAMe
formed was then eluted with two fractions of 3 ml of 3 N
ammonium hydroxide. The s-adenosyl-L-methionineBMC Veterinary Research 2009, 5:10 http://www.biomedcentral.com/1746-6148/5/10
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formed was determined by counting in 10 ml F-1 Nor-
mascint scintillation liquid (Scharlau). The reaction was
linear with time for at least 30 min.
Phospholipid Met Tase was determined as described else-
where [25]. This method is based on the determination of
the incorporation of [3H]methyl groups from S-adenosyl-
L-(methyl-3H)methionine (Radiochemical Center, Amer-
sham, Buckinghamshire, UK) into phospholipids. The
reaction mixture contained 10 Mm 4,2-hydroxyethyl-1-
piperazine ethanesulfonic acid (HEPES) (pH 7.3), 4 mM
dithiothreitol, 5 mM MgCl2, 100 μM S-adenosyl methio-
nine, 2 μCi S-adenosyl-L-(methyl-3H)methionine and 50
μl of sample. The reaction was initiated by the addition of
a mixture of the labelled and unlabeled S-adenosyl
methionine and terminated by pipetting 100 μl assay mix-
ture into 2 ml chloroform/methanol/2 N HCl (6:3:1, v/v/
v) for lipid extraction. The chloroform phase was washed
with 1 ml 0.5 M KCl in 50% methanol. After washing, 0.6
ml of the chloroform phase was pipetted into a counting
vial, dried at room temperature, dissolved into 5 ml Nor-
mascint-11 scintillation liquid (Scharlau) and counted.
Results are expressed in relation to the concentration of
tissue proteins to correct differences in the amount of cell
per surface, secondary to intestinal wall dilation. Protein
determination was performed by the Bradford method.
The basis of this method is the addition of Coomassie
brilliant blue dye/colorant to proteins. This union induces
a shift in maximum dye absorbance from 465 to 595 nm.
Absorbance is measured at 595 nm, comparing to a
known standard curve.
Reproducibility within the assays was evaluated in three
independent experiments. Each assay was carried out with
three replicates. In all assays, the intra-assay coefficient of
variation was <5%, and the inter-assay coefficient of vari-
ation was <6%.
Statistical analysis
Results are expressed as the mean ± SEM. Mean compari-
son was done by the Kuskal-Wallis test followed by a
Mann Whitney test; a confidence level of 95% (p < 0.05)
was considered significant.
Results
MAT activity was reduced in both, distal and proximal
portions of jejunum obtained of colic horses, compared
with the MAT activity observed in the intestine of healthy
horses (Fig. 1A). Met Tase activity was also lower in the
portion of intestine proximal to the stenosis compared to
the distal group, however, no differences were observed
between distal portion and healthy horses (Fig. 1B).
GSH content of tissue distal to the stenosis was signifi-
cantly lower than that of the healthy horses, and a further
reduction was observed in the proximal portion (Fig. 2).
By contrary, LPO levels were lower in intestinal tissue of
healthy horses compared with colic horses. LPO levels
were higher in cells from the proximal portion as com-
pared to those from the distal portion (Fig. 3).
As shown in figure 4, ATP content followed a pattern sim-
ilar to that of GSH. ATP was reduced in the proximal por-
tion to the stenosis compared to the distal one.
The NO and CO content (released by) in mitochondria
gave higher values in the proximal portion as compared
with the distal group (Fig. 5). No differences were
observed between distal portion and healthy horses.
Discussion
It is generally accepted that the intestinal mucosa is
extremely sensitive to ischemia. Ischemia injury causes
misdistribution of blood flow, damage to endothelium,
coagulation abnormalities, and aggregation of platelets
and neutrophils. The activation of neutrophils leads to the
release of reactive oxygen species (ROS) including super-
oxide anion (O2
-) and H2O2.
Methionine adenosyl transferase (MAT) and methyl trans- ferase (MetTase) activities in jejunum of colic horses Figure 1
Methionine adenosyl transferase (MAT) and methyl 
transferase (MetTase) activities in jejunum of colic 
horses.BMC Veterinary Research 2009, 5:10 http://www.biomedcentral.com/1746-6148/5/10
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Free radicals generated by polymorphonuclear leucocytes,
macrophages and other cells, may have a role in intestinal
dysfunction secondary to ischemia [1,5,26]. One of the
most immediate actions of free radicals is the peroxida-
tion of membrane lipids which is implicated as the under-
lying cause of cell injury in many conditions involving
oxidative stress. Although the mechanisms of lipid perox-
idation have been extensively studied, controversy still
remains as to the critical and irreversible steps leading to
cell injury and the therapeutic potential of intervention
Glutathione (GSH) content of jejunum homogenates Figure 2
Glutathione (GSH) content of jejunum homogenates.
Lipid peroxides (LPO) content of jejunum homogenates Figure 3
Lipid peroxides (LPO) content of jejunum homoge-
nates.
Adenosyl triphosphate (ATP) content jejunum homogenates Figure 4
Adenosyl triphosphate (ATP) content jejunum 
homogenates.
Nitric oxide (NO) and carbon monoxide (CO) level in jeju- num homogenates Figure 5
Nitric oxide (NO) and carbon monoxide (CO) level 
in jejunum homogenates.BMC Veterinary Research 2009, 5:10 http://www.biomedcentral.com/1746-6148/5/10
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[27]. In this study, we measured LPO levels as damage
indices in the intestine. We found a considerable increase
in the intestinal tissue levels of LPO in the outer parts of
resected intestine segments isolated from colic horses
compared with those isolated from healthy horses, and
this increase was more marked in the proximal portion to
the stenosis compared with the distal portion, indicating
that free radicals, secondary to intestinal ischemia, pro-
mote the peroxidation of intestinal lipids. Interestingly,
higher LPO levels were also found in the distal (macro-
scopically viable) portion of intestine resected compared
with those isolated from healthy horses. We can specu-
lated that the ischemic intestine releases proinflammatory
molecules, such as hydrogen peroxide (H2O2), superoxide
radicals (O2
-), cytokines (e.g., tumour necrosis factor-α),
and arachidonic acid metabolites into the portal and sys-
temic circulation, all of which can induce direct tissue
damage. However, these molecules are also potent activa-
tors of leukocytes and thereby promote their sequestra-
tion to the neighborhood, increasing damage to intestine.
Several inflammatory mediators can be released during
equine colic [3,28]. Nitric Oxide (NO) is one molecular
mediator involved in both the inflammatory response
[29] and oxidative damage [8,30]. During defence reac-
tions there seems to be a close relationship between both
free radicals and NO production. NO reacts with oxygen
to yield peroxynitrites, which is a strong oxidant.
In accordance with previous reports, which show that
iNOS activity and NO release are increased after ischemia
injury in several tissues [31-33], in the present study NO
release to the mitochondrial fraction was found to be
increased in the portion of jejunum proximal to the sten-
osis compared with the distal group. It is likely that NO is
produced in the intestinal tissue during different proc-
esses such as vascular regulation and host defence. In
addition, it is conceivable that NO produced by any cell
may exert paracrine effects in neighboring cells, then
amplifying tissue damage.
GSH is probably the most important cellular antioxidant.
There is evidence for an evolutionary link between GSH
and eukaryotic cell metabolism [34] indicating that GSH
evolved as a molecule that protects cells against oxygen
toxicity. Intracellular GSH acts both as a nucleophilic
"scavenger", converting electrophylic compounds to
thioether conjugates, and as a substrate in the GSH perox-
idase-mediated destruction of hydroperoxides [35]. GSH
can prevent covalent binding of reactive metabolites to
critical cellular macromolecules and lipid peroxidation
[14], both of which are major mechanisms mediating cell
injury and/or death. Glutathione (GSH) deficiency leads
to severe degeneration of the epithelial cells of the jeju-
num and colon [16]. Administration of GSH have a pro-
tective effect on the gastrointestinal epithelium and may
also serve as a good source of cysteine for intracellular
GSH synthesis in the gastrointestinal tract and in other tis-
sues [16]. In this study, a reduction in GSH levels in the
portion of jejunum proximal to the stenosis was observed.
This fact could be either cause or consequence of the
increase in the intestinal ischemia-related oxidative/anti-
oxidative imbalance.
SAMe, an endogenous cellular metabolite that acts as
methyl donor in most of biological transmethylation
reactions, is also able to act as an antioxidant and free rad-
ical scavenger in vitro [36]. It has also shown to exert pro-
tective effects on different experimental pathological
models, in which free radicals and ROS are involved, such
as brain ischemia-reperfusion [37], cytokine-induced tox-
icity [38], liver cirrhosis [39-42], cholestatic liver disease
[43-46] and in the exposure to hepatotoxic agents [17].
Thus it seemed interesting to look into the implication of
this molecule during equine colic, during which, release
of free radicals seems to be involved [1,5].
A decrease in MAT activity in the outer parts of resected
jejunum segments isolated from colic horses compared
with those isolated from healthy horses has been found in
this study, and this decrease was more marked in the prox-
imal portion of stenosis compared with the distal portion.
This finding is in accordance with previous studies in
humans and experimental animals, in which a decrease in
liver-specific MAT activity in several pathological situa-
tions was observed [17,25,39]. However, to our knowl-
edge this is the first work showing a decrease in MAT
activity in the intestine of colic horses with intestinal
ischemia. This reduction in MAT activity would lead to a
decrease in SAMe synthesis, which would affect many
essential metabolic pathways in which SAMe is involved,
such as GSH synthesis. Oxidative stress could be involved
in this intestinal ischemia-related decrease in MAT activ-
ity, since it is known that both ROS [47,48] and NO [49]
are able to inactivate liver MAT. This situation would lead
to a self-perpetuating cycle, in which the free radicals gen-
erated would induce a GSH depletion, thus increasing oxi-
dative stress that would inactivate MAT, which would
further reduce SAMe and GSH synthesis [50,51].
On the other hand, in our study intestinal ischemia
induced an increase in cellular oxidative stress (as shown
by the increase in LPO content) and NO release, and these
factors could account for the reduction in MAT activity.
This decrease in MAT activity has been proposed to be an
adaptative mechanism to spare ATP, whose levels are usu-
ally compromised under pathological situations, by
reducing its consumption in SAMe and GSH synthesis and
leaving it available for other basic cellular functions [17].
In this study, a reduction in GSH levels in the portion ofBMC Veterinary Research 2009, 5:10 http://www.biomedcentral.com/1746-6148/5/10
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jejunum proximal to the stenosis was also found, which
could be both cause and consequence of the decrease in
MAT activity.
SAMe can also contribute to preserve cell membrane
integrity, preventing membrane lipid peroxidation and
maintaining phospholipid methylation, and membrane
fluidity. In this study, we also found a colic-associated
decrease in MetTase activity, a fact that has also been
found in other pathological situations [25,52]. Given that
Met Tase plays an important role catalyzing the methyla-
tion of phosphatidyl ethanolamine to produce phosphati-
dyl choline (PC), which is an essential molecule for cell
membrane integrity, we can hypothesized that this
decrease in Met Tase could contribute to ischemia-
induced intestinal tissue injury.
It is known that impairment in mitochondrial function,
may lead to an increase in the rate of ROS production in
mitochondria and this fact could be a major mechanism
for the intestinal ischemia-related increase in oxidative
damage in colic horses. Impairment in structure and/or
mitochondrial function may lead to a reduction of the
energy supply to the cells. These observations are in
accordance with our present results, in which a decrease in
ATP content of the intestinal tissue resected from colic
horses, compared with those obtained from healthy
horses. Accumulation of oxidative damage could be
involved in this phenomenon, since oxidative stress is
able to inhibit mitochondrial respiration [6] leading to
organ dysfunction and cell death.
CO is a physiologically synthesized molecule that shares
some of the mechanisms of action and physiological
effects of NO [9,53]. The main endogenous source of CO
is heme metabolism by heme-oxygenase (HO) [9,53].
This HO-CO pathway has been recently proposed to be
involved in the defence against oxidative stress and the
deleterious effects of NO, since it removes the cytotoxic
free heme, and produces some molecules with antioxi-
dant and anti-inflammatory effects, such as biliverdin and
CO [9,54-56]. Therefore, this pathway could be activated
to counteract an excess of oxidant and inflammatory
agents [9]. The present study shows that intestinal
ischemia induces an increase in local CO production in
intestine, and this fact could mean that this defence mech-
anism has been activated by the increase in colic-associ-
ated ROS and proinflammatory molecules, such as NO.
Conclusion
In conclusion, our results suggest that intestinal ischemia
in horses can be accompagnied with an oxidative/antiox-
idative imbalance. This effect could be mediated, at least
in part by impairment in glutathione and/or SAMe metab-
olism, suggesting a possible application for these mole-
cules in the preventive and/or therapeutic approach to
intestinal ischemia-induced damage. Further investiga-
tion is needed to elucidate their efficacy and establish if
they can be used clinically.
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